Immune thrombotic thrombocytopenic purpura in patients over 60 years of age: diagnostic pitfalls and treatment strategy
Lester, Will
Lester, Will
Abstract
Real-world registry studies of older patients with iTTP highlight diagnostic difficulties in comparison to patients less than 60 years of age with greater risk of renal injury, atypical neurological features and less profound cytopenia, which can result in diagnostic delays. However, there is no clear signal of significantly increased toxicity from full active treatment. Commentary on: Gómez-Seguí et al. Immune thrombotic thrombocytopenic purpura in older patients: results from the Spanish TTP Registry (REPTT).
MIDER Authors
Citations
Altmetric:
Date
2023-09-25
Type
Correspondence
Subject
Haematology
Collections
Citation
Lester W. Immune thrombotic thrombocytopenic purpura in patients over 60 years of age: Diagnostic pitfalls and treatment strategy. Br J Haematol. 2023 Dec;203(5):704-705. doi: 10.1111/bjh.19123. Epub 2023 Sep 25.
Journal / Source Title
British Journal of Haematology
DOI
10.1111/bjh.19123
PMID
37749067
Publisher
Wiley
Publisher’s URL
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.19123